Integrin αDβ2 influences cerebral edema, leukocyte accumulation and neurologic outcomes in experimental severe

Isaclaudia G de Azevedo-Quintanilha1, Adriana Vieira-de-Abreu1, André C Ferreira1

  • 1Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Rio de Janeiro, Brazil.

Plos One
|December 24, 2019
PubMed

Insights

Deleting the αD integrin subunit reduced mortality in experimental severe malaria by decreasing leukocyte infiltration and preserving blood-brain barrier integrity. This suggests a novel therapeutic target for cerebral malaria.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Neuroscience

Background:

  • Malaria, particularly cerebral malaria, is a life-threatening infectious disease.
  • Leukocyte integrins play crucial roles in immune responses and disease pathogenesis.
  • Previous studies indicated that deleting the αD integrin subunit reduces mortality in experimental malaria.

Purpose of the Study:

  • To investigate the mechanisms by which αD integrin deletion protects against severe malaria.
  • To examine the role of αDβ2 integrin in leukocyte infiltration and blood-brain barrier integrity during cerebral malaria.

Main Methods:

  • Comparison of wild-type and αD-/- mice infected with Plasmodium berghei ANKA.
  • Intravital microscopy to assess leukocyte rolling and adhesion in cerebral vessels.
  • Flow cytometry to quantify T-lymphocyte accumulation in the brain.
  • Evans blue dye exclusion assay to evaluate blood-brain barrier integrity.
  • Assessment of aversive memory in infected mice.

Main Results:

  • αD-/- mice exhibited significantly reduced vessel plugging and leukocyte infiltration in the brain compared to WT mice.
  • Leukocyte rolling and adhesion in cerebral vessels were decreased in αD-/- mice.
  • T-lymphocyte accumulation in the brain and blood-brain barrier disruption were reduced in αD-/- mice.
  • αD-/- mice did not show the impaired aversive memory observed in chloroquine-treated WT mice.

Conclusions:

  • Deletion of integrin αDβ2 significantly alters the course of experimental severe malaria.
  • αDβ2 integrin plays a critical role in immune-inflammatory responses mediating cerebral malaria.
  • Targeting αDβ2 integrin may offer a novel therapeutic strategy for severe malaria and cerebral complications.